Abstract:Purpose: NEMO-deficient patients present with variable degrees of immunodeficiency. Accordingly, treatment ranges from antibiotic prophylaxis and/or IgG-substitution to allogenic hematopoietic stem cell transplantation (HSCT). The correct estimation of the immunodeficiency is essential to avoid over- as well as under-treatment. We compare the immunological phenotype of a NEMO-deficient patient with a newly-described splice site mutation that causes truncation of the NEMO zinc-finger (ZF) domain and a severe clinical course with the immunological phenotype of three NEMO-deficient patients with missense mutations and milder clinical courses and all previously published patients. Methods: Lymphocyte subsets, proliferation, and intracellular NEMO-expression were assessed by FACS. NF-κB signal transduction was determined by measuring IκBα-degradation and the production of cytokines upon stimulation with TNF-α, IL-1β, and TLR-agonists in immortalized fibroblasts and whole blood, respectively. Results: The patient with truncated ZF-domain of NEMO showed low levels of IgM and IgG, reduced class-switched memory B cells, almost complete skewing towards naïve CD45RA+ T cells, impaired T cell proliferation as well as cytokine production upon stimulation with TNF-α, IL-1β, and TLR-agonists. He suffered from severe infections (sepsis, pneumonia, osteomyelitis) during infancy. In contrast, three patients with missense mutations in IKBKG presented neither skewing of T cells towards naïvety nor impaired T cell proliferation. They are stable on prophylactic IgG-substitution or even off any prophylactic treatment. Conclusion: The loss of the ZF-domain and the impaired T cell proliferation accompanied by almost complete persistence of naïve T cells despite severe infections are suggestive for a profound immunodeficiency. Allogenic HSCT should be considered early for these patients before chronic sequelae occur.

A Mutation of Ikbkg Causes Immune Deficiency Without Impairing Degradation of IκBα

IKBKG (nuclear factor-kappa B essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function

A Nonsense Mutation in IKBKB Causes Combined Immunodeficiency.

An Exclusive NEMO B Mutation Leads to NF-κB-linked Recurrent Pneumonia by Disrupting the NEMO/IKK Complex

Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-independent Type 2 Antigens

Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype

EDA-ID and IP, Two Faces of the Same Coin: How the Same IKBKG / NEMO Mutation Affecting the NF-κB Pathway Can Cause Immunodeficiency and/or Inflammation

T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency

A Novel Homozygous Mutation Destabilizes Ikk Beta And Leads To Human Combined Immunodeficiency

Non-Skewed X-inactivation Results in NF-κB Essential Modulator (NEMO) Δ-exon 5-autoinflammatory Syndrome (NEMO-NDAS) in a Female with Incontinentia Pigmenti

Mutation of the ER Retention Receptor KDELR1 Leads to Cell-Intrinsic Lymphopenia and a Failure to Control Chronic Viral Infection

Deficiency of IκB Kinase Β in Myeloid Cells Reduces Severity of Experimental Autoimmune Encephalomyelitis.

Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation

Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency

MyD88 protein destabilization mitigates NF-κB-dependent protection against macrophage apoptosis

Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].

Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses

IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice

IκBNS Expression in B Cells is Dispensable for IgG Responses to T Cell-Dependent Antigens

A spontaneous mutation in NCR1 locus reveals an inhibitory role for IFNγ response by NCR1 via inhibiting dok-1 phosphorylation

Mlkl Knockout Mice Demonstrate the Indispensable Role of Mlkl in Necroptosis